Xiangxue Pharmaceutical (300147) — Free Cash Flow Generation Index
Xiangxue Pharmaceutical (300147) has a Free Cash Flow Generation Index of 0.92x as of September 2025. Free cash flow of CN¥69.90 Million represents 1% of operating cash flow (CN¥75.64 Million). See working capital position of Xiangxue Pharmaceutical to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Xiangxue Pharmaceutical Free Cash Flow Generation Index (2007–2025)
Historical FCF Generation Index trend for Xiangxue Pharmaceutical across 19 annual periods. Explore Xiangxue Pharmaceutical cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Xiangxue Pharmaceutical (2007–2025)
Year-by-year Free Cash Flow Generation Index for Xiangxue Pharmaceutical. For the full company profile including market capitalisation, see 300147 stock market capitalisation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.85x | CN¥118.12 Million | CN¥139.63 Million | CN¥21.51 Million | ▲ +190.1% |
| 2024 | -0.94x | CN¥-17.07 Million | CN¥18.17 Million | CN¥35.24 Million | ▼ -219.3% |
| 2023 | 0.79x | CN¥207.41 Million | CN¥263.44 Million | CN¥56.03 Million | ▲ +228.0% |
| 2022 | -0.62x | CN¥-139.89 Million | CN¥227.38 Million | CN¥367.27 Million | ▲ +48.1% |
| 2021 | -1.18x | CN¥-305.18 Million | CN¥257.56 Million | CN¥562.74 Million | ▲ +32.3% |
| 2020 | -1.75x | CN¥-450.24 Million | CN¥257.18 Million | CN¥707.42 Million | ▲ +74.9% |
| 2019 | -6.96x | CN¥-578.07 Million | CN¥83.02 Million | CN¥661.09 Million | ▼ -57.2% |
| 2018 | -4.43x | CN¥-404.23 Million | CN¥91.24 Million | CN¥495.46 Million | ▲ +27.4% |
| 2017 | -6.10x | CN¥-668.33 Million | CN¥109.53 Million | CN¥777.87 Million | ▲ +31.5% |
| 2016 | -8.91x | CN¥-1.77 Billion | CN¥198.48 Million | CN¥1.97 Billion | ▼ -1116.4% |
| 2015 | -0.73x | CN¥-117.06 Million | CN¥159.89 Million | CN¥276.95 Million | ▼ -54.9% |
| 2014 | -0.47x | CN¥-78.27 Million | CN¥165.58 Million | CN¥243.85 Million | ▼ -1681.0% |
| 2013 | 0.03x | CN¥9.82 Million | CN¥328.37 Million | CN¥318.55 Million | ▲ +101.2% |
| 2012 | -2.52x | CN¥-299.22 Million | CN¥118.91 Million | CN¥418.12 Million | ▲ +63.0% |
| 2011 | -6.81x | CN¥-201.13 Million | CN¥29.55 Million | CN¥230.69 Million | ▼ -2614.0% |
| 2010 | -0.25x | CN¥-11.40 Million | CN¥45.47 Million | CN¥56.87 Million | ▼ -73.6% |
| 2009 | -0.14x | CN¥-6.67 Million | CN¥46.19 Million | CN¥52.86 Million | ▲ +90.2% |
| 2008 | -1.47x | CN¥-81.99 Million | CN¥55.72 Million | CN¥137.71 Million | ▼ -2924.4% |
| 2007 | -0.05x | CN¥-6.71 Million | CN¥138.02 Million | CN¥144.73 Million | — |